arrow
A

Alexander P. Benz

university hospital mainz
H指数:25
被引数:2,272

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Early recurrence of atrial arrhythmia following catheter ablation of atrial tachycardia consecutive to ablation of atrial fibrillation using the updated blanking period

房性心动过速导管消融术后早期复发,继发于房颤消融术后更新的空白期使用

2026-02-010
OA
Early recurrence of atrial arrhythmia and healthcare utilization during the 8-week blanking period following thermal energy catheter ablation of atrial fibrillation

心房心律失常的早期复发及在心房颤动热能导管消融术后8周空白期内的医疗资源利用

2025-12-080
OAAI
Monitoring time-to-detection of recurrent atrial fibrillation in patients with transient new-onset atrial fibrillation detected initially during hospitalization for noncardiac surgery or medical illness

监测因非心脏手术或内科疾病住院期间初次发现的一过性新发房颤患者中复发性房颤的检测时间

2025-10-100
OAAI
Apixaban for stroke prevention in subclinical atrial fibrillation detected by an implantable cardiac monitor: a subgroup analysis of ARTESiA

阿哌沙班用于由植入式心脏监护仪检测到的亚临床房颤患者的卒中预防:ARTESiA研究的亚组分析

2025-08-050
PRE
Artificial intelligence for direct-to-physician reporting of ambulatory electrocardiography

用于直接面向医师报告的动态心电图的人工智能

2025-02-102
OA
Neuroglial Biomarkers for Risk Assessment of Ischemic Stroke and Other Cardiovascular Events in Patients With Atrial Fibrillation Not Receiving Oral Anticoagulation

神经胶质生物标志物在未接受口服抗凝治疗的房颤患者缺血性卒中和其他心血管事件风险评估中的应用

2025-01-210
PRE
Risk of Stroke or Systemic Embolism According to Baseline Frequency and Duration of Subclinical Atrial Fibrillation: Insights From the ARTESiA Trial

根据亚临床房颤的基线频率和持续时间,中风或全身性栓塞的风险: 来自ARTESiA试验的见解

2024-11-260
PRE